Cytosorbents (CTSO)
(Real Time Quote from BATS)
$0.90 USD
+0.02 (2.27%)
Updated May 31, 2024 01:44 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.12 |
Last EPS Surprise | 0.00% |
ABR | 1.67 |
Earnings ESP
|
3.57% |
---|---|
Current Year | -0.36 |
Next Year | -0.21 |
EPS (TTM) | -0.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.73M | 9.89M | 39.51M | 46.83M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 9.82M | 10.48M | 41.33M | 49.76M |
Low Estimate | 9.68M | 9.40M | 37.72M | 44.24M |
Year ago Sales | 9.42M | 8.81M | 36.35M | 39.51M |
Year over Year Growth Est. | 3.32% | 12.29% | 8.70% | 18.53% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.08 | -0.36 | -0.21 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.09 | -0.09 | -0.36 | -0.24 |
High Estimate | -0.09 | -0.08 | -0.34 | -0.16 |
Low Estimate | -0.10 | -0.09 | -0.38 | -0.28 |
Year ago EPS | -0.14 | -0.21 | -0.64 | -0.36 |
Year over Year Growth Est. | 35.71% | 61.90% | 43.75% | 40.74% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 2 | 2 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.08 | -0.36 | -0.21 |
7 Days Ago | -0.09 | -0.08 | -0.36 | -0.21 |
30 Days Ago | -0.10 | -0.08 | -0.36 | -0.17 |
60 Days Ago | -0.10 | -0.08 | -0.46 | -0.21 |
90 Days Ago | -0.11 | -0.09 | -0.48 | -0.21 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.08 | -0.36 | -0.24 |
Zacks Consensus Estimate | -0.09 | -0.08 | -0.36 | -0.21 |
Earnings ESP | 3.57% | 0.00% | 0.00% | -12.50% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.12 | -0.12 | -0.21 | -0.14 | NA |
Estimate | -0.12 | -0.14 | -0.12 | -0.11 | NA |
Difference | 0.00 | 0.02 | -0.09 | -0.03 | -0.03 |
Surprise | 0.00% | 14.29% | -75.00% | -27.27% | -22.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more